Concomitant tumor resistance (CR) is a phenomenon in which a tumor-bearing host is
resistant to the growth of secondary tumor implants. This phenomenon has been described …

Advance care planning (ACP) and goals of care designation (GCD) are being integrated into
modern health care. In cirrhosis, uptake and adoption of these practices have been limited …

Background. Transplantation of pancreatic islets for the treatment of type 1 diabetes allows
for physiologic glycemic control and insulin-independence when sufficient islets are …

Obeticholic acid (OCA), a potent farnesoid X receptor agonist, was studied as monotherapy
in an international, randomized, double‐blind, placebo‐controlled phase 2 study in patients …

Concomitant tumor resistance (CR) is a phenomenon in which a tumor-bearing host is
resistant to the growth of secondary tumor implants and metastasis. Although previous …

To achieve permanent correction of Wilson's disease by a cell therapy approach,
replacement of diseased hepatocytes with healthy hepatocytes is desirable. There is a …

Concomitant tumor resistance (CR) is a phenomenon originally described in 1906 in which
a tumor-bearing host is resistant to the growth of secondary tumor implants and metastasis …

Transplantation of mature islets into portal vein has been most effective thus far, although
attrition of transplanted islets constitutes a major limitation, and alternative approaches are …

Introduction This paper presents anatomic studies of decellularized human placenta and
cow placentome and proves that there is a possibility to create a scaffold using the natural …

An auxiliary liver represents a promising alternative for liver transplantation. The use of a
large amount of mature hepatocytes, however, despite their high function, is limited in a …